BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 35578896)

  • 21. Comprehensive genomic characterization of cutaneous malignant melanoma cell lines derived from metastatic lesions by whole-exome sequencing and SNP array profiling.
    Cifola I; Pietrelli A; Consolandi C; Severgnini M; Mangano E; Russo V; De Bellis G; Battaglia C
    PLoS One; 2013; 8(5):e63597. PubMed ID: 23704925
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic progression of malignant melanoma.
    Tímár J; Vizkeleti L; Doma V; Barbai T; Rásó E
    Cancer Metastasis Rev; 2016 Mar; 35(1):93-107. PubMed ID: 26970965
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IGFBP-5 overexpression as a poor prognostic factor in patients with urothelial carcinomas of upper urinary tracts and urinary bladder.
    Liang PI; Wang YH; Wu TF; Wu WR; Liao AC; Shen KH; Hsing CH; Shiue YL; Huang HY; Hsu HP; Chen LT; Lin CY; Tai C; Wu JY; Li CF
    J Clin Pathol; 2013 Jul; 66(7):573-82. PubMed ID: 23539739
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predicting progression of bladder urothelial carcinoma using microRNA expression.
    Rosenberg E; Baniel J; Spector Y; Faerman A; Meiri E; Aharonov R; Margel D; Goren Y; Nativ O
    BJU Int; 2013 Nov; 112(7):1027-34. PubMed ID: 23387295
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gene Expression Profile of the Clinically Aggressive Micropapillary Variant of Bladder Cancer.
    Guo CC; Dadhania V; Zhang L; Majewski T; Bondaruk J; Sykulski M; Wronowska W; Gambin A; Wang Y; Zhang S; Fuentes-Mattei E; Kamat AM; Dinney C; Siefker-Radtke A; Choi W; Baggerly KA; McConkey D; Weinstein JN; Czerniak B
    Eur Urol; 2016 Oct; 70(4):611-620. PubMed ID: 26988609
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship between p53 gene mutation and protein expression: clinical significance in transitional cell carcinoma of the bladder.
    Gao JP; Uchida T; Wang C; Jiang SX; Matsumoto K; Satoh T; Minei S; Soh S; Kameya T; Baba S
    Int J Oncol; 2000 Mar; 16(3):469-75. PubMed ID: 10675477
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comprehensive Genomic Sequencing of Urothelial Tumors Identifies Rare SMARCB1 (INI-1)-Deficient Carcinomas of the Urinary System.
    Gupta S; Albertson D; Gaston D; Heilbrun ME; Agarwal N; Boucher K; Parnell TJ; Liu T; Morgans A; Madison R; Gowen K; Miller VA; Ross JS; Ali SM; Millis SZ
    Clin Genitourin Cancer; 2018 Apr; 16(2):e373-e382. PubMed ID: 28974397
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of tumour location versus multifocality in patients with upper tract urothelial carcinoma treated with nephroureterectomy and bladder cuff excision: a homogeneous series without perioperative chemotherapy.
    Yafi FA; Novara G; Shariat SF; Gupta A; Matsumoto K; Walton TJ; Fritsche HM; El-Hakim A; Trischler S; Martínez-Salamanca JI; Seitz C; Ficarra V; Zattoni F; Karakiewicz PI; Kassouf W
    BJU Int; 2012 Jul; 110(2 Pt 2):E7-13. PubMed ID: 22177329
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Promoter Methylation of PTEN Is a Significant Prognostic Factor in Melanoma Survival.
    Roh MR; Gupta S; Park KH; Chung KY; Lauss M; Flaherty KT; Jönsson G; Rha SY; Tsao H
    J Invest Dermatol; 2016 May; 136(5):1002-1011. PubMed ID: 26854490
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comprehensive genomic profiling of 295 cases of clinically advanced urothelial carcinoma of the urinary bladder reveals a high frequency of clinically relevant genomic alterations.
    Ross JS; Wang K; Khaira D; Ali SM; Fisher HA; Mian B; Nazeer T; Elvin JA; Palma N; Yelensky R; Lipson D; Miller VA; Stephens PJ; Subbiah V; Pal SK
    Cancer; 2016 Mar; 122(5):702-11. PubMed ID: 26651075
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Non-urothelial tumors of the urinary tract].
    Mikuz G
    Verh Dtsch Ges Pathol; 1993; 77():180-98. PubMed ID: 7511278
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Study of mutated p53 protein by immunohistochemistry in urothelial neoplasm of urinary bladder.
    Roychowdhury A; Dey RK; Bandyapadhyay A; Bhattacharya P; Mitra RB; Dutta R
    J Indian Med Assoc; 2012 Jun; 110(6):393-6. PubMed ID: 23360043
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Independent prognostic factors for initial intravesical recurrence after laparoscopic nephroureterectomy for upper urinary tract urothelial carcinoma.
    Liu Y; Lu J; Hong K; Huang Y; Ma L
    Urol Oncol; 2014 Feb; 32(2):146-52. PubMed ID: 23628312
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular changes during progression from nonmuscle invasive to advanced urothelial carcinoma.
    Sjödahl G; Eriksson P; Patschan O; Marzouka NA; Jakobsson L; Bernardo C; Lövgren K; Chebil G; Zwarthoff E; Liedberg F; Höglund M
    Int J Cancer; 2020 May; 146(9):2636-2647. PubMed ID: 31609466
    [TBL] [Abstract][Full Text] [Related]  

  • 35. No evidence for mutation of B-RAF in urothelial carcinomas of the bladder and upper urinary tract.
    Stoehr R; Brinkmann A; Filbeck T; Gamper C; Wild P; Blaszyk H; Hofstaedter F; Knuechel R; Hartmann A
    Oncol Rep; 2004 Jan; 11(1):137-41. PubMed ID: 14654916
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High expression of Chitinase 3-like-1 is an unfavorable prognostic factor in urothelial carcinoma of upper urinary tract and urinary bladder.
    Lee YE; Chan TC; Tian YF; Liang PI; Shiue YL; Chen YS; He HL
    Urol Oncol; 2019 May; 37(5):299.e7-299.e18. PubMed ID: 30660494
    [TBL] [Abstract][Full Text] [Related]  

  • 37. miR‑367 enhances the proliferation and invasion of cutaneous malignant melanoma by regulating phosphatase and tensin homolog expression.
    Long J; Luo J; Yin X
    Mol Med Rep; 2018 May; 17(5):6526-6532. PubMed ID: 29512776
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FGF7 Over Expression is an Independent Prognosticator in Patients with Urothelial Carcinoma of the Upper Urinary Tract and Bladder.
    Fan EW; Li CC; Wu WJ; Huang CN; Li WM; Ke HL; Yeh HC; Wu TF; Liang PI; Ma LJ; Li CF
    J Urol; 2015 Jul; 194(1):223-9. PubMed ID: 25623741
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Muscle-invasive bladder cancer developing after nephroureterectomy for upper urinary tract urothelial carcinoma.
    Kim KH; You D; Jeong IG; Hong JH; Ahn H; Kim CS
    Urol Oncol; 2013 Nov; 31(8):1643-9. PubMed ID: 22591745
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genomic predictors of survival in patients with high-grade urothelial carcinoma of the bladder.
    Kim PH; Cha EK; Sfakianos JP; Iyer G; Zabor EC; Scott SN; Ostrovnaya I; Ramirez R; Sun A; Shah R; Yee AM; Reuter VE; Bajorin DF; Rosenberg JE; Schultz N; Berger MF; Al-Ahmadie HA; Solit DB; Bochner BH
    Eur Urol; 2015 Feb; 67(2):198-201. PubMed ID: 25092538
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.